Phase I study of a combination of capecitabine plus CPT-11 (CC therapy) in patients with metastatic colon cancer refractory to oxaliplatin containing chemotherapy
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: CPT-11 150mg/m2(day1) Capecitabine Xmg/m2, p.o.(day2-8) to be repeated every 2 weeks for four course Primary outcome(s): Dose limiting toxicity, safety Study Design: Single arm Non-randomized
创建时间：
2010-02-15
